Seres Therapeutics, Inc.
Industry: Life Sciences ・ $MCRB on Nasdaq
Insider Sale
+$11,545
-6.89%
Shares
Shares Volume: 8,552 Shares
Average Share Price: $1.35
INSIDER
Shaff Eric D.
CEO and President (Director)
reported on Oct 31 2023
traded on Oct 27 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 115,620 |
PURCHASES/SALES 1Y | 0 / 1 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $11,545.2 |
INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 6 |
PURCHASES/SALES 1Y | 0 / 7 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $10,614.12 |
COMPANY PREVIOUS TRADES |